Summary: Financial Performance: Edwards Lifesciences reported a 11.6% year-over-year revenue growth, with strong sales in their TAVR, TMTT,…
Summary: Edwards Lifesciences reported strong growth in total sales, driven by diversified product performance across geographies and therapies,…
Sign in to your account